Several signaling pathways are involved both in early tumorigenesis of PC and in androgen-refractory disease, for which no curative treatment exists currently, among them MAPKs, NF-κB, and Akt pathways [6]. The gene discussed is AKT1; the disease is pachyonychia congenita.